Janssen-Cilag wins NICE approval for psoriasis drug Stelara
September 23, 2009Sales and Marketing JJ, NICE, Stelara
NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …
Gerresheimer invests further in plastic packaging
September 23, 2009Manufacturing and Production packaging
Gerresheimer has continued its expansion into the pharmaceutical plastic packaging sector with the construction of two new plants, one in …
GlaxoSmithKline to reform US medical education funding
September 23, 2009Medical Communications CME, US, ethics
GlaxoSmithKline has announced a major shift in its policy for paying for medical education programmes for doctors in the US.The …
Contract research news in brief
September 22, 2009Research and Development CRO
Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …
Pfizer and Icagen extend pain drug deal
September 22, 2009Research and Development Icagen, Pfizer
Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …
AZ strikes drug development deal with Nektar Therapeutics
September 22, 2009Research and Development AZ, Nektar
AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
Safety First
September 22, 2009Research and Development, Sales and Marketing EU, US, reg, safety
A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …
Doctors’ leaders hit out at hospital funding proposals
September 21, 2009NHS, hc
The British Medical Association has hit out at health secretary Andy Burnham's ideas to link hospital funding to measures of …
Merck sells Merial share, but retains animal health option
September 21, 2009Sales and Marketing Merck, Merial, Sanofi, animal health
Merck & Co has got rid of its interest in animal health products company Merial prior to the merger with …
WHO welcomes pandemic vaccine donations to developing world
September 21, 2009Sales and Marketing h1n1, hc, vaccines
The World Health Organisation has applauded donations of H1N1 vaccine made by the US, Australia, Brazil, France, Italy, New Zealand, …
CambReg and SIRO forge strategic alliance
September 21, 2009Sales and Marketing generics
UK contract research organisation Cambridge Regulatory Services has teamed up with one of its Indian counterparts – SIRO Clinpharm – …
Publication bias still evident in US trials database
September 18, 2009Medical Communications, Sales and Marketing ethics
A study showing that two-thirds of clinical trials included in the US national register had no record of their primary …
Renovo cuts jobs after takeover talks fail
September 18, 2009Research and Development Renovo
UK biotech Renovo is planning to reduce its headcount by over a third after a takeover approach from an unnamed …
Daniel Vasella, chief executive and chairman Novartis
September 17, 2009Sales and Marketing Novartis, Vasella
FDA warns Bayer over German API facility
September 17, 2009Manufacturing and Production Bayer, FDA, reg
The US regulator has sent a warning letter to Bayer indicating it found "significant deviations from US current good manufacturing …
GPs gain QOF concessions in return for swine flu work
September 17, 2009NHS, qof
GPs are to administer swine flu jabs in the government’s forthcoming vaccination scheme in return for some administrative concessions.These include …
ABPI defends OLS Blueprint against member scepticism
September 17, 2009ABPI
Over half of ABPI members believe the government's latest efforts to help the life sciences sector will not make a …
Merck’s osteoporosis candidate shows some promise in trials
September 16, 2009Research and Development, Sales and Marketing Cancer, Merck
Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
